Keyphrases
Antiviral Activity
38%
Antiviral Immune Response
7%
Antiviral Immunity
15%
Antiviral Response
7%
Astrocytes
100%
Astrogliosis
7%
Attenuation
7%
Cocaine
100%
Cognitive Sequelae
7%
Drugs of Abuse
7%
Dysregulation
7%
Environmental Toxins
7%
Gene Transcription
7%
HIV-1 Virus
7%
HIV-associated Neurocognitive Disorders
7%
Human Immunodeficiency Virus Type 1 (HIV-1)
30%
Immune Factors
7%
Infected Individual
7%
Inflammation
7%
Inflammatory Pathways
7%
Innate Antiviral Response
100%
Innate Immune Signaling
15%
Interferon Signaling
7%
Interferon-α (IFN-α)
7%
Molecular Biology Techniques
7%
Neurocognitive Disorders
7%
Neurotropic
7%
Oxidative Stress
100%
Pattern Recognition Receptors
7%
Phosphorylation
7%
Pioglitazone
23%
Pre-exposure
7%
Propentofylline
23%
Protective Behavior
7%
Reactive Oxygen Species Production
7%
Response Pathways
100%
RNA Virus
7%
Signaling Factors
7%
Signaling Pathway
15%
Single-stranded DNA (ssDNA)
15%
Stimulator of Interferon Genes (STING)
7%
Therapeutic Potential
7%
Transcription Factor E3 (TFE3)
7%
Type I Interferon
23%
Type I Interferon Response
7%
Type I Interferon Signaling
7%
Virus
7%
Zika Virus
38%
Zika Virus Infection
7%
Medicine and Dentistry
Antiviral Immune Response
12%
Antiviral Immunity
25%
Antivirus Agent
100%
Astrocyte
100%
Astrocytosis
12%
Cell Signaling Pathway
25%
Disorders of Higher Cerebral Function
12%
Double Stranded DNA
25%
Environmental Toxin
12%
Genetic Transcription
12%
HIV-associated Neurocognitive Disorder
12%
Human Immunodeficiency Virus
62%
In Vitro
12%
Interferon
37%
Interferon Type I
50%
Oxidative Stress
100%
Pattern Recognition Receptor
12%
Pioglitazone
37%
Propentofylline
37%
Reactive Oxygen Species
12%
RNA Virus
12%
Sequela
12%
Transcription Factor 3
12%
Type 1 Astrocyte
12%
Virus
12%
Zika Fever
12%
Zika Virus
62%
Immunology and Microbiology
Antiviral Immune Response
14%
Antiviral Immunity
28%
Astrocyte
100%
Genetic Transcription
14%
Human Immunodeficiency Virus
14%
Human Immunodeficiency Virus 1
71%
In Vitro
14%
interferon
100%
Oxidative Stress
100%
Pattern Recognition Receptor
14%
Pretreatment
14%
Propentofylline
42%
RNA Virus
14%
Transcription Factor 3
14%
Type 1 Astrocyte
14%
Viral Disease
14%
Virus
14%
Zika Virus
85%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Astrocytosis
9%
Disorders of Higher Cerebral Function
9%
Double Stranded DNA
18%
HIV
45%
HIV Associated Dementia
9%
Inflammation
9%
Interferon
27%
Interferon Type I
36%
Pattern Recognition Receptor
9%
Pioglitazone
27%
Propentofylline
27%
Reactive Oxygen Metabolite
9%
RNA Virus
9%
Transcription Factor 3
9%
Zika Fever
9%
Zika Virus
45%